Magnus Unemo
Magnus Unemo is a prominent researcher at Örebro University in Sweden, known for his work on antimicrobial resistance in Neisseria gonorrhoeae. He contributed to the commentary accompanying a study on gepotidacin, emphasizing the potential for the drug to face resistance as well, and the need for ongoing development of additional treatments for gonorrhea.
Not in the pool (under ¢1).
Recent news mentions
Magnus Unemo of Örebro University warned about the ongoing challenges in retaining gonorrhea as a treatable infection.
FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance
United States· 2025-12-12
Magnus Unemo is a professor at UCL in London and leads the work at the laboratory in Örebro.
Könsjukdomen gonorré ökar – resistenta stammar oroar
Sweden· 2025-07-27
Magnus Unemo is a researcher who wrote in a Lancet editorial about the potential for N. gonorrhoeae to develop gepotidacin resistance.
Promising new antibiotic is one of first viable gonorrhea drug candidates since 1990s
Canada· 2025-04-15
Magnus Unemo is from Örebro University in Sweden and commented on the potential resistance of gonorrhea to gepotidacin.
Gepotidacin: New antibiotic is effective against gonorrhea, could be first new treatment since 1990s, study saysUnited States· 2025-04-14
